Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756990 · ClinicalTrials.gov registry record · NA
Depot Naltrexone Treatment of Opioid Dependent Parolees
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT00756990: Completed NA study, sponsored by University of Pennsylvania.
NCT00756990 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00756990, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
This is an investigation involving the use of a long-acting, injectable form (depot) of naltrexone as a treatment for persons who have a history of opioid dependence, with up to 40 on parole/probation and 20 non-parolees. The test is a pilot study of up to 60 subjects treated with 6 months of depot naltrexone plus Psychosocial Treatment .
Interventions
- DRUG Depot Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2005-11 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00756990
The ClinicalTrials.gov registry entry for NCT00756990 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Depot Naltrexone is the first listed.
NCT00756990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00756990 about?
NCT00756990 is a clinical study titled "Depot Naltrexone Treatment of Opioid Dependent Parolees". This is an investigation involving the use of a long-acting, injectable form (depot) of naltrexone as a treatment for persons who have a history of opioid dependence, with up to 40 on parole/probation and 20 non-parolees. The test is a pilot study of up to 60 subjects treated with 6 months of depot ...
What is the current status of trial NCT00756990?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2005-11. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00756990?
The interventions under investigation include: Depot Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00756990?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.